Code | 8636A | ||||||||||
MA number | 29/0016/14-S | ||||||||||
Product Form: | tbl flm 50x400 mg (liek.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product not subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 22.01.2014 |
Pediatric posology: | Yes |
Pediatric contraindication: | Yes |
SPC: | SPC_Ibuprofen Dr.Max 400 mg filmom obalené tablety_03.2024.pdf |
PIL: | PIL_Ibuprofen Dr.Max 400 mg filmom obalené tablety_03.2024.pdf |
Safety feature | No |
Data update: | 07.05.2019 |